GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yili Chuannig Biotechnology Co Ltd (SZSE:301301) » Definitions » Current Deferred Revenue

Yili Chuannig Biotechnology Co (SZSE:301301) Current Deferred Revenue : ¥0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Yili Chuannig Biotechnology Co Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Yili Chuannig Biotechnology Co's current deferred revenue for the quarter that ended in Mar. 2024 was ¥0 Mil.

Yili Chuannig Biotechnology Co Current Deferred Revenue Historical Data

The historical data trend for Yili Chuannig Biotechnology Co's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yili Chuannig Biotechnology Co Current Deferred Revenue Chart

Yili Chuannig Biotechnology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
Get a 7-Day Free Trial - - - - -

Yili Chuannig Biotechnology Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Yili Chuannig Biotechnology Co Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Yili Chuannig Biotechnology Co's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Yili Chuannig Biotechnology Co (SZSE:301301) Business Description

Traded in Other Exchanges
N/A
Address
No. 516, Almatua Village, Yining Park, Horgos Economic Development Zone, Xinjiang, Ili, CHN, 835000
Yili Chuannig Biotechnology Co Ltd adopts the most advanced and mature international biological fermentation, chemical extraction, enzymatic hydrolysis, control and energy saving, and environmental protection technology. The main products of the company include erythromycin thiocyanate, cephalosporin intermediates, penicillin intermediates, and crude ursodeoxycholic acid.

Yili Chuannig Biotechnology Co (SZSE:301301) Headlines

No Headlines